Search Tag: lung cancer
2023 11 Sep
A study presented at the International Association for the Study of Lung Cancer 2023 World Conference on Lung Cancer revealed that key reproductive factors such as early menopause, shortened reproductive span, and early age at first birth are associated with elevated risks of lung cancer in women. Researchers from Xiangya Hospital, Changsha,...Read more
2023 23 Jun
Lung cancer is the leading cause of cancer death in the U.S. Early detection of lung cancer improves survival chances, but lung cancer screening rates are much lower than those of other cancer screening tests. Placing prompts in the electronic health record systems will help to remind primary care physicians of patients’ eligibility for lung...Read more
2023 08 Jun
Vaclav Potesil is the Chief Business Officer and Founder of Optellum, an Oxford-based company dedicated to transforming lung cancer treatment. Unfortunately, lung cancer is the most common type of cancer and the leading cause of cancer deaths in the world, claiming more lives than breast cancer and prostate cancer combined. However, with the rapid...Read more
2023 10 May
LUNGevity Foundation, the nation’s leading lung cancer-focused nonprofit organization, is pleased to welcome Leah Fine, MBA, as the vice president of its soon-to-be-launched Early Lung Cancer Center. LUNGevity takes a holistic approach to accelerate early detection and early disease management through research, public policy, health equity, and lung...Read more
2022 18 Nov
In a cohort study of 685 adults with a positive lung cancer screening examination, adherence to recommended care improved among those with a higher suspicion of lung cancer, as well as after extending the follow-up timeline. The study was published in JAMA Network. Recruited individuals were aged 18 years and over who underwent lung cancer...Read more
2022 27 Jan
Facilitating decisions using vast amounts of comparative data – AI can do this, but creating the algorithms is a complex and lengthy process. Yet it can make a difference, especially in lung cancer care. The lack of early symptoms and the aggressive progression of lung cancer make it one of the deadliest types of cancer.[1] Individually adapted...Read more
2021 21 Dec
Most physicians agree that discovering lung cancer early is critical to saving lives. Over 200,000 people receive lung cancer diagnoses annually and this remains a leading causes of U.S. cancer deaths. For the first time, a large retrospective population study, conducted by researchers at Icahn School of Medicine at Mount Sinai, demonstrated this. The study...Read more
2021 09 Nov
Researchers at Brigham and Women’s Hospital (Boston, MA) recently published a study in the Journal of the American College of Radiology showing that patient retention in a lung cancer screening (LCS) programme drops after diagnostic chest computed tomography (CT) examinations. Lung cancer is the leading cause of US cancer-related death, and screening...Read more
2021 14 Oct
Siemens Healthineers recently added non-small cell lung cancer support to its AI Pathway Companion. Currently supported pathways are non-small cell lung and prostate cancer. Siemens first presented its AI Pathway Companion at the 2018 Annual Meeting of the Radiological Society of North America in Chicago. In summary, the system delivers artificial...Read more
2021 10 Aug
New AI solution enables personalized decision making along the lung cancer pathway Facilitates patient management and case reviews by combining into a single dashboard Second pathway for AI-Pathway Companion after pathway for prostate cancer Siemens Healthineers presents its second pathway for its AI-Pathway Companion 1 at the...Read more
2021 18 Feb
A deep learning (DL) model developed at the Pennsylvania State University proved to be much more efficient in predicting survival expectancy of lung cancer patients than the traditional ML models (Doppalapudi et al. 2021). You might also like: Deep learning models are more efficient at discerning patterns and discriminative features...Read more
2019 04 Dec
Affidea and Aidence announce a strategic partnership to streamline and improve the clinical performance of lung diagnosis and screening to drive the earlier detection and treatment in the case of lung cancer. As the leading European provider of advanced diagnostic imaging services, Affidea is starting the collaboration with Aidence, a medical...Read more
2019 03 Jun
On Thursday April 18, The Value-Based Health Care Prize was awarded to Good Life with Osteoarthritis in Denmark (GLA:D®) . Besides the prize, four excellence awards and the inspirational award were awarded to five inspiring initiatives. This year, a total of thirteen initiatives were nominated by the international expert jury to compete for...Read more
2018 19 Sep
New Yale-led research demonstrates that thermal ablation is safe and effective in the treatment of early-stage lung cancer. Since ablation uses no radiation, thus reducing medical cost, this approach may be a viable option for patients who cannot undergo lung cancer surgery because of age or health status, according to the study published in the...Read more
2018 22 May
New research highlights the need for more efforts to promote lung cancer screening, as only 1.9 percent of more than 7 million current and former heavy smokers were screened for lung cancer in 2016. The study is the first to examine lung cancer screening rates since the United States Preventive Services Task Force (USPSTF) issued screening recommendations...Read more
2018 27 Feb
About 1.6 million people die of lung cancer each year, making it the leading cause of cancer-related deaths in the world. The poor outcomes of treatment in lung cancer resulting from the fact that most cases are diagnosed in the advanced stage of the disease justify the implementation of an optimal lung cancer prevention in the form of smoking cessation...Read more
2017 28 Nov
During an overcrowded exhilarating session on Monday 27th November at the RSNA 2017 Congress in Chicago, Dr. Hugo Aerts, from Harvard University in Cambridge, explained to delegates that artificial intelligence (AI) is indeed playing a pivotal role in the development of new imaging biomarkers for lung cancer. A key topic of interest...Read more
2017 26 Sep
New research demonstrates that dynamic first-pass contrast-enhanced (CE) perfusion area-detector CT (ADCT) is as useful as FDG PET/CT for the differentiation of metastatic from nonmetastatic lymph nodes and assessment of N stage in patients with non-small cell lung carcinoma (NSCLC). In addition, researchers found that using mathematic methods and...Read more
2017 19 Sep
A new study sought to describe patient experience and acceptability of whole-body magnetic resonance imaging (WB-MRI) as a potential replacement for the modalities currently used for staging lung and colorectal cancer. The findings, published in the journal BMJ Open, confirm that WB-MRI can be a challenging experience and that staff support is important...Read more
2017 15 Aug
Lung cancer screening has demonstrated a reduction in lung cancer mortality by 20 percent. Annual low-dose computed tomography (LDCT) screening in high-risk individuals is now recommended by multiple national healthcare organisations. As such, lung cancer screening is projected to increase the case volume for the thoracic surgery workforce....Read more